CoinBucha

Companies › Bitcoin treasury companies

Apimeds Pharmaceuticals US (APUS)

NYSE American · United States · Admitted on 2026-10-05, pending review. Joins 2026-12-31.

1,005BTC

as of 2026-06-30

Checked against the company's filing. No company pays to be listed, ranked or edited here.

Cite: CoinBucha (2026). Apimeds Pharmaceuticals US bitcoin holdings, as of 2026-06-30. https://coinbucha.com/listed-bitcoin/apimeds-pharmaceuticals

Holdings source

Bitcoin exposure per share

BTC per share
0.000666 BTC
2026-06-30 · shares 2026-08-12
USD per share
$39.15
BTC close 2026-11-20
Per $1,000 invested
$24,469
0.416 BTC · APUS $1.60, 2026-11-20
% of market cap
2446.9%
close 2026-11-20

Above 300% of market cap: past the methodology's record-check line (rule R6). A measure this high admits nothing on its own; its inputs are checked before the next review. Rule

Next results date
—
None announced in the investor calendar
Index status
Pending
from 2026-12-31

Key facts

Market cap
$2.4M
1.5M shares · 1.6 USD
mNAV
0.041×
vs $59.1M of bitcoin · what is mNAV

Peers in this class

Bitcoin treasury companies

About

The share count is after the 1-for-10 reverse split of 2026-07-24. The same filing records outstanding Series A convertible preferred stock, which is not common stock and is not counted.

Sources & identifiers

ISIN — · FIGI BBG01Q0T3FL7 · LEI — · MIC XASE

bitcoin valued at $58,798.98 (BTC/USD close 2026-11-20) · methodology v2.0 · corrections log